7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Sarcoma, Ewing D012512 2 associated lipids
Urologic Neoplasms D014571 2 associated lipids
Tooth Mobility D014086 2 associated lipids
Bacteroidaceae Infections D016866 2 associated lipids
Microvascular Angina D017566 2 associated lipids
Otosclerosis D010040 2 associated lipids
Root Resorption D012391 2 associated lipids
Dermatomyositis D003882 2 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Labyrinthitis D007762 2 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Bjerre M et al. Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trial. 2014 Scand. J. Clin. Lab. Invest. pmid:25026506
Lee HJ et al. Association between polymorphisms in leptin, leptin receptor, and β-adrenergic receptor genes and bone mineral density in postmenopausal Korean women. 2014 Menopause pmid:23760429
Jun AY et al. Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts. 2014 Invest New Drugs pmid:23673814
Kuroyanagi G et al. Suppression by resveratrol of prostaglandin D2-stimulated osteoprotegerin synthesis in osteoblasts. 2014 Prostaglandins Leukot. Essent. Fatty Acids pmid:24813642
Guo L et al. Association between seven common OPG genetic polymorphisms and osteoporosis risk: a meta-analysis. 2014 DNA Cell Biol. pmid:24283361
Samara S et al. Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis. 2014 Exp. Mol. Pathol. pmid:24200492
Bastos MF et al. Effects of Cachaça, a typical Brazilian alcoholic beverage, on alveolar bone loss and density: a study in peripubertal rats. 2014 Arch. Oral Biol. pmid:24183604
Park K et al. Increased OPG/RANKL ratio in the conditioned medium of soybean-treated osteoblasts suppresses RANKL-induced osteoclast differentiation. 2014 Int. J. Mol. Med. pmid:24248634
El-Hoss J et al. Modulation of endochondral ossification by MEK inhibitors PD0325901 and AZD6244 (Selumetinib). 2014 Bone pmid:24269278
Casarin RC et al. Resveratrol improves bone repair by modulation of bone morphogenetic proteins and osteopontin gene expression in rats. 2014 Int J Oral Maxillofac Surg pmid:24530035
Tang ZL et al. An experimental study addressing the promotion of mandibular defect repair through the intermittent subcutaneous injection of parathyroid hormone. 2014 J. Oral Maxillofac. Surg. pmid:24071373
Steffens JP et al. Testosterone regulates bone response to inflammation. 2014 Horm. Metab. Res. pmid:24526374
Puato M et al. Impact of hypertension on vascular remodeling in patients with psoriatic arthritis. 2014 J Hum Hypertens pmid:23842084
Hooshmand S et al. The effect of dried plum on serum levels of receptor activator of NF-κB ligand, osteoprotegerin and sclerostin in osteopenic postmenopausal women: a randomised controlled trial. 2014 Br. J. Nutr. pmid:24780728
Park MK et al. Halofuginone ameliorates autoimmune arthritis in mice by regulating the balance between Th17 and Treg cells and inhibiting osteoclastogenesis. 2014 pmid:24782183
Nakamura M et al. [Cytokine-mediated bone resorption]. 2014 Clin Calcium pmid:24870834
Nakashima T [Coupling and communication between bone cells]. 2014 Clin Calcium pmid:24870836
Shimamura M et al. OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:24847069
Ghorbanihaghjo A et al. Osteoprotegerin and soluble receptor activator of nuclear factor-kappa B ligand in exudative age-related macular degeneration. 2014 Acta Med Iran pmid:24901855
Dumnicka P et al. Osteoprotegerin, trail and osteoprotegerin/trail ratio in patients at early phase of acute pancreatitis. 2014 Folia Med Cracov pmid:25648306
Shi W et al. Osteoprotegerin is up-regulated in pancreatic cancers and correlates with cancer-associated new-onset diabetes. 2014 Biosci Trends pmid:25641178
Ma Y et al. Acetylcholine affects osteocytic MLO-Y4 cells via acetylcholine receptors. 2014 Mol. Cell. Endocrinol. pmid:24508663
Wu H et al. Ginsenoside metabolite compound K attenuates inflammatory responses of adjuvant-induced arthritis rats. 2014 Immunopharmacol Immunotoxicol pmid:24450920
Park YJ et al. Prediction of subclinical atherosclerosis by serum osteoprotegerin in premenopausal women with systemic lupus erythematous: correlation of osteoprotegerin with monocyte chemotactic protein-1. 2014 Lupus pmid:24531425
Chen W et al. Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:24733914
Hong YY et al. Fibroblasts regulate variable aggressiveness of syndromic keratocystic and non-syndromic odontogenic tumors. 2014 J. Dent. Res. pmid:24972872
Akiyama N et al. Limitation of immune tolerance-inducing thymic epithelial cell development by Spi-B-mediated negative feedback regulation. 2014 J. Exp. Med. pmid:25385757
Lv Y et al. Effects of pamidronate disodium on the loss of osteoarthritic subchondral bone and the expression of cartilaginous and subchondral osteoprotegerin and RANKL in rabbits. 2014 BMC Musculoskelet Disord pmid:25377946
D'Abramo A et al. Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis. 2014 Mediators Inflamm. pmid:25374442
Samir SM and Malek HA Effect of cannabinoid receptors 1 modulation on osteoporosis in a rat model of different ages. 2014 J. Physiol. Pharmacol. pmid:25371528
Arrigoni C et al. Direct but not indirect co-culture with osteogenically differentiated human bone marrow stromal cells increases RANKL/OPG ratio in human breast cancer cells generating bone metastases. 2014 Mol. Cancer pmid:25335447
Cardelli M and Aubin JE ERRγ is not required for skeletal development but is a RUNX2-dependent negative regulator of postnatal bone formation in male mice. 2014 PLoS ONE pmid:25313644
Kim JY et al. (2S)-2'-Methoxykurarinone inhibits osteoclastogenesis and bone resorption through down-regulation of RANKL signaling. 2014 Biol. Pharm. Bull. pmid:24492722
Movérare-Skrtic S et al. Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures. 2014 Nat. Med. pmid:25306233
Holt V et al. Identification of a subpopulation of marrow MSC-derived medullary adipocytes that express osteoclast-regulating molecules: marrow adipocytes express osteoclast mediators. 2014 PLoS ONE pmid:25302610
Moran CS et al. Osteoprotegerin deficiency limits angiotensin II-induced aortic dilatation and rupture in the apolipoprotein E-knockout mouse. 2014 Arterioscler. Thromb. Vasc. Biol. pmid:25301844
Hayashida C et al. Osteocytes produce interferon-β as a negative regulator of osteoclastogenesis. 2014 J. Biol. Chem. pmid:24610813
Schündeln MM et al. Impairment of bone health in pediatric patients with hemolytic anemia. 2014 PLoS ONE pmid:25299063
Callegari A et al. Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6. 2014 J. Vasc. Res. pmid:24642764
Nascimento MM et al. Elevated levels of plasma osteoprotegerin are associated with all-cause mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney disease. 2014 Braz. J. Med. Biol. Res. pmid:25296363
Kuroyanagi G et al. Down-regulation by resveratrol of basic fibroblast growth factor-stimulated osteoprotegerin synthesis through suppression of Akt in osteoblasts. 2014 Int J Mol Sci pmid:25290095
Brabnikova-Maresova K et al. Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis. 2014 Arthritis Res. Ther. pmid:25280749
Wohlfahrt JC et al. Sulcus fluid bone marker levels and the outcome of surgical treatment of peri-implantitis. 2014 J. Clin. Periodontol. pmid:24417563
Park SY et al. Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment. 2014 Toxicol. Appl. Pharmacol. pmid:24463094
Davaine JM et al. Osteoprotegerin, pericytes and bone-like vascular calcification are associated with carotid plaque stability. 2014 PLoS ONE pmid:25259713
Wang B et al. Chondrocyte β-catenin signaling regulates postnatal bone remodeling through modulation of osteoclast formation in a murine model. 2014 pmid:24431282
Yokota K et al. Combination of tumor necrosis factor α and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo. 2014 pmid:24431283
Polyzos SA et al. Denosumab treatment for juvenile Paget's disease: results from two adult patients with osteoprotegerin deficiency ("Balkan" mutation in the TNFRSF11B gene). 2014 J. Clin. Endocrinol. Metab. pmid:24433001
Inanc M et al. Nuclear factor-kappa B ligand and osteoprotegerin levels in serum and gingival crevicular fluid in patients with bone metastases treated with zoledronic acid. 2014 Med. Oncol. pmid:24448976
Canalis E et al. Nemo-like kinase regulates postnatal skeletal homeostasis. 2014 J. Cell. Physiol. pmid:24664870
Lee EJ et al. PTX3 stimulates osteoclastogenesis by increasing osteoblast RANKL production. 2014 J. Cell. Physiol. pmid:24664887
Tao K et al. Influences of IL-6R antibody on PMMA bone cement-mediated expression of OPG and RANKL in synovial fibroblasts. 2014 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:24710939
Pullisaar H et al. Simvastatin coating of TiOâ‚‚ scaffold induces osteogenic differentiation of human adipose tissue-derived mesenchymal stem cells. 2014 Biochem. Biophys. Res. Commun. pmid:24704451
Chaganti RK et al. Elevation of serum tumor necrosis factor α in patients with periprosthetic osteolysis: a case-control study. 2014 Clin. Orthop. Relat. Res. pmid:24307062
Bandeira F et al. Bone markers and osteoporosis therapy. 2014 Arq Bras Endocrinol Metabol pmid:25166041
Foo JP et al. The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea. 2014 J. Clin. Endocrinol. Metab. pmid:25148234
Warren JT et al. Manipulation of receptor oligomerization as a strategy to inhibit signaling by TNF superfamily members. 2014 Sci Signal pmid:25140055
Yan D et al. Serum levels of M-CSF, RANKL and OPG in rats fed with Kashin-Beck disease-affected diet. 2014 J Orthop Surg Res pmid:25138985
Schieferdecker A et al. Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL. 2014 Oncotarget pmid:25138051
Chung SL et al. Low-magnitude high-frequency vibration enhances gene expression related to callus formation, mineralization and remodeling during osteoporotic fracture healing in rats. 2014 J. Orthop. Res. pmid:25131218
Yoshida S et al. An osteoprotegerin gene polymorphism is associated with an increased risk of hip fracture in Japanese patients with rheumatoid arthritis: results from the IORRA Observational Cohort Study. 2014 PLoS ONE pmid:25105978
Li T et al. Rabbiteye blueberry prevents osteoporosis in ovariectomized rats. 2014 J Orthop Surg Res pmid:25102951
Kwan JS et al. Meta-analysis of genome-wide association studies identifies two loci associated with circulating osteoprotegerin levels. 2014 Hum. Mol. Genet. pmid:25080503
Yang X et al. [Preliminary study on the best-exerted force chance in the female menstrual cycle]. 2014 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:25033640
Zhou DA et al. Influence of glucocorticoids on the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. 2014 BMC Musculoskelet Disord pmid:25027542
Rechenberg DK et al. Periapical fluid RANKL and IL-8 are differentially regulated in pulpitis and apical periodontitis. 2014 Cytokine pmid:25022970
Ohlsson C et al. Probiotics protect mice from ovariectomy-induced cortical bone loss. 2014 PLoS ONE pmid:24637895
Nogueira AV et al. Biomechanical loading modulates proinflammatory and bone resorptive mediators in bacterial-stimulated PDL cells. 2014 Mediators Inflamm. pmid:24976684
Loureiro MB et al. Low bone mineral density is associated to poor glycemic control and increased OPG expression in children and adolescents with type 1 diabetes. 2014 Diabetes Res. Clin. Pract. pmid:24529565
Weichhaus M et al. Osteoprotegerin expression in triple-negative breast cancer cells promotes metastasis. 2014 Cancer Med pmid:24976340
Tera Tde M et al. The RANK/ RANKL/ OPG interaction in the repair of autogenous bone grafts in female rats with estrogen deficiency. 2014 Braz Oral Res pmid:25229791
Lis GJ et al. Elevated serum osteoprotegerin is associated with decreased osteoclastic differentiation in stenotic aortic valves. 2014 J. Physiol. Pharmacol. pmid:24930509
Huang C et al. The inhibitory effect of strontium-doped calcium polyphosphate particles on cytokines from macrophages and osteoblasts leading to aseptic loosening in vitro. 2014 Biomed Mater pmid:24518283
Simpson CA et al. Serum levels of sclerostin, Dickkopf-1, and secreted frizzled-related protein-4 are not changed in individuals with high bone mass causing mutations in LRP5. 2014 Osteoporos Int pmid:24927689
Izawa A et al. Inflammatory bone loss in experimental periodontitis induced by Aggregatibacter actinomycetemcomitans in interleukin-1 receptor antagonist knockout mice. 2014 Infect. Immun. pmid:24566623
Fuernau G et al. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial. 2014 Eur. J. Heart Fail. pmid:24903195
Knevel R et al. A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis. 2014 Arthritis Res. Ther. pmid:24886600
Kyvernitakis I et al. Effect of aromatase inhibition on serum levels of sclerostin and dickkopf-1, bone turnover markers and bone mineral density in women with breast cancer. 2014 J. Cancer Res. Clin. Oncol. pmid:24903965
Todenhöfer T et al. Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy. 2014 BJU Int. pmid:23360112
Candido R The osteoprotegerin/tumor necrosis factor related apoptosis-inducing ligand axis in the kidney. 2014 Curr. Opin. Nephrol. Hypertens. pmid:24247823
Khan IS et al. Enhancement of an anti-tumor immune response by transient blockade of central T cell tolerance. 2014 J. Exp. Med. pmid:24752296
Rody WJ et al. Differences in the gingival crevicular fluid composition between adults and adolescents undergoing orthodontic treatment. 2014 Angle Orthod pmid:23687969
Inubushi T et al. Lactoferrin inhibits infection-related osteoclastogenesis without interrupting compressive force-related osteoclastogenesis. 2014 Arch. Oral Biol. pmid:24370195
Huang JW et al. Osteoprotegerin, inflammation and dyslipidemia are associated with abdominal aortic calcification in non-diabetic patients on peritoneal dialysis. 2014 Nutr Metab Cardiovasc Dis pmid:24361071
Deng L et al. Tissue distribution of emulsified γ-tocotrienol and its long-term biological effects after subcutaneous administration. 2014 Lipids Health Dis pmid:24712339
Chung PL et al. Effect of age on regulation of human osteoclast differentiation. 2014 J. Cell. Biochem. pmid:24700654
Sirjani M et al. The effects of high fat, low carbohydrate and low fat, high carbohydrate diets on tumor necrosis factor superfamily proteins and proinflammatory cytokines in C57BL/6 mice. 2014 Iran J Allergy Asthma Immunol pmid:24659160
Wang JH et al. Association of serum osteoprotegerin levels with carotid-femoral pulse wave velocity in hypertensive patients. 2014 J Clin Hypertens (Greenwich) pmid:24640954
Liu YP et al. Association of the g.27563G>A osteoprotegerin genetic polymorphism with bone mineral density in Chinese women. 2014 Genet. Mol. Res. pmid:24615112
Ovchinnikova OA et al. The collagen cross-linking enzyme lysyl oxidase is associated with the healing of human atherosclerotic lesions. 2014 J. Intern. Med. pmid:24588843
Montes de Oca A et al. Magnesium inhibits Wnt/β-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells. 2014 PLoS ONE pmid:24586847
Ostrowska Z et al. Bone metabolism, osteoprotegerin, receptor activator of nuclear factor-κB ligand and selected adipose tissue hormones in girls with anorexia nervosa. 2014 Endokrynol Pol pmid:24549600
Rachner TD et al. Dickkopf-1 is regulated by the mevalonate pathway in breast cancer. 2014 Breast Cancer Res. pmid:24528599
Zanotti S et al. Sex and genetic factors determine osteoblastic differentiation potential of murine bone marrow stromal cells. 2014 PLoS ONE pmid:24489784
Aksu F et al. The relation between the levels of osteoprotegerin and the degree of coronary artery disease in patients with acute coronary syndrome and stable angina pectoris. 2014 Kardiol Pol pmid:24469748
Scialla JJ et al. Biomarkers of vascular calcification and mortality in patients with ESRD. 2014 Clin J Am Soc Nephrol pmid:24458076
Ohba T et al. Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of MCP-1 and RANKL. 2014 J. Bone Miner. Res. pmid:24443409
Pobeha P et al. Circulatory osteoprotegerin is related to osteoporosis of the hip in patients with COPD. 2014 Respir Med pmid:24424018
Kinney JS et al. Crevicular fluid biomarkers and periodontal disease progression. 2014 J. Clin. Periodontol. pmid:24303954
Chauvat A et al. Clinical validation of IFNγ/IL-10 and IFNγ/IL-2 FluoroSpot assays for the detection of Tr1 T cells and influenza vaccine monitoring in humans. 2014 Hum Vaccin Immunother pmid:24084262

Table of Content